about
MannKind Corp is a biopharmaceutical company focused on the development and commercialization of patient-centric therapies that address serious unmet medical needs for those living with cardiometabolic and orphan lung diseases. The Company is current...
Read More
3.90
-0.03
(-0.76%)
330.2K
XNAS Volume
XNAS 11 Aug, 2026 9:41 AM (EDT)
Not Eligible
Expensive Valuation
Technically Neutral
Mannkind Corp Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..